Companies: 10,795·Total market cap: $144.5T
Iterum Therapeutics plc

Iterum Therapeutics plc

ITRMNASDAQHealthcare
$0.03
$-0.00(-10.98%)
Market Cap$1598747
P/E Ratio—
52W High$1.42
52W Low$0.0271
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Iterum Therapeutics plc (ITRM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001659323 · ITRM · NASDAQ · as of Jun 9, 2026

Filing snapshot

508
Total Filings
8-K
Latest Form
2026-03-31
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001659323 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-02-07
Fiscal Year End
Feb 7, 2025
Accession No.
0000950170-25-015857
Primary Document
itrm-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001659323 · Accession 0000950170-25-015857

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2026-03-31Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-03-31
View
8-KCurrent Report
8-K
2026-03-27
View
8-KCurrent Report
8-K
2026-03-03
View
8-KCurrent Report
8-K
2026-03-02
View
8-KCurrent Report
8-K
2026-02-18
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-02-13
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-01-26
View
DEF 14AProxy Statement
DEF 14A
2026-01-02
View
PRE 14APRE 14A
PRE 14A
2025-12-23
View
8-KCurrent Report
8-K
2025-12-12
View
10-QQuarterly Report
10-Q
2025-11-14
View
8-KCurrent Report
8-K
2025-11-14
View
8-KCurrent Report
8-K
2025-10-16
View
424B5424B5
424B5
2025-10-16
View
8-KCurrent Report
8-K
2025-09-10
View
Showing 1–15 of 361 filingsForm 4 / 144 hidden· 508 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001659323  |  Exchange: NASDAQ · Healthcare

Iterum Therapeutics plc (NASDAQ: ITRM) has submitted 508 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001659323, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Iterum Therapeutics plc's most comprehensive regulatory disclosure. The most recent Iterum Therapeutics plc 10-K was filed on 2025-02-07 for fiscal year ending 2025. Historical ITRM 10-K annual reports are available from 2015 through 2025.

Investors researching Iterum Therapeutics plc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
QTTB SEC Filings →ANTX SEC Filings →RLYB SEC Filings →BOLD SEC Filings →IBIO SEC Filings →PLUR SEC Filings →KLTO SEC Filings →TAOX SEC Filings →
→ ITRM Financials→ ITRM Earnings→ ITRM Insider Trades

Frequently Asked Questions

ITRM SEC Filings · 8 questions

Iterum Therapeutics plc (ITRM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 508 filings and access original documents at no cost. Iterum Therapeutics plc's CIK is 0001659323.

ITRM SEC filingsIterum Therapeutics plc SEC documentsfind ITRM 10-K